Long-term NMN helped aging mice preserve metabolic and physical function
June 11, 2026
English digest
One of the most famous NAD+ precursor studies did not promise immortality; it showed something subtler and more useful: aging mice stayed metabolically younger for longer.
In a 2016 Cell Metabolism paper, Kathryn Mills, Shohei Yoshida, Liana Stein and colleagues asked whether nicotinamide mononucleotide, or NMN, could offset the age-related drop in NAD+ availability. They administered NMN orally to normal C57BL/6N mice for 12 months during natural aging, using doses designed to raise tissue NAD+ rather than force weight loss through dietary restriction. The team tracked body composition, energy metabolism, insulin sensitivity, plasma lipids, eye function, physical activity, mitochondrial markers, inflammatory gene expression, and signs of toxicity.
Continue reading this digest
What they found · Why it matters for longevity
Read full digest →Premium — $7/month · Cancel anytime
Join 1,200+ readers following longevity science
Source paper
Mills KF, Yoshida S, Stein LR et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
Read the original paper